ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Merck writes off big bet on CETP drug anacetrapib
fiercebiotech
October 13, 2017Merck, the last big firm standing in the once-hyped CETP field, has opted against filing for approval of anacetrapib. The Big Pharma reached the decision after going over a mixed set of data from its big bet on a phase 3 program.
Pharma Sources Insight January 2025
